Conference Reports for NATAP
The Liver Meeting
AASLD 2025
Washington, D.C.
November 7-11, 2025
Back
Real-World Experience of Seladelpar Among Patients With Primary Biliary Cholangitis Including Patients Who Switched From Obeticholic Acid
AASLD 2025 Nov 7-11 Wash DC
Christopher L. Bowlus1
